Iturralde E, et al. - After accounting for depression and medical comorbidity, researchers studied the connection of anxiety with high-cost use among individuals with type 2 diabetes. Using electronic health record data of 143,573 adults with type 2 diabetes from an integrated health care system, they evaluated past anxiety diagnosis, health care use and costs, demographics, comorbidities, and diabetes control status and complications from 2008-2012. From 2008-2011, 12.9% of respondents were diagnosed with anxiety; 52.9% had also been diagnosed with depression. Anxiety among people with type 2 diabetes is extremely comorbid with depression and is independently linked with high-cost resource use. Anxiety was positively linked to number of ED visits in 2012; likelihood of visiting the ED on a chronic, frequent basis during 2010–2012; and high-cost status in 2012. Anxiety was not related to total hospitalization costs in 2012. Strategies to enhance management of anxiety in individuals with diabetes can decrease the cost of health care.